Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

(2010) Hans Rasmussen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Quetiapine

(2009) Anna Sparshatt et al.   CNS DRUGS

Dosing Quetiapine in Drug-Naive First-Episode Psychosis

(2009) Gregor E. Berger et al.   JOURNAL OF CLINICAL PSYCHIATRY

Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse Agonist

(2009) S. Snigdha et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

(2009) Herbert Y Meltzer et al.   NEUROPSYCHOPHARMACOLOGY

Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia

(2008) Brian Dean et al.   SCHIZOPHRENIA RESEARCH